Concepedia

Janardhana Vemula

JV

2

Publications

35

Citations

2

H-Index

2016

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis (India)

Janardhana Vemula is an author at Novartis (United States) specializing in drug safety, pharmacotherapy, and epidemiology.

Top concepts

MedicineDrug SafetyEpidemiologyPharmacologyDrug ResistancePharmacotherapyPharmacogenomics

Publications per year

2016–2019

2

Publications

2

A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers

Kiran Dole, Florencia Segal, Adam L. Feire et al. · Antimicrobial Agents and Chemotherapy · 2016 · 25 citations · Full text

Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes

Birk Poller, Ralph Woessner, Avantika Barve et al. · Pulmonary Pharmacology & Therapeutics · 2019 · 10 citations

Drug Safety, Co-medication Pharmacokinetics, Different Slco1b1 Genotypes +7

Rows per page

1–2 of 2